SCIENTIFIC BACKGROUND

ALDOBFBP1

Hereditary fructose intolerance (HFI) is a severe autosomal recessive inherited metabolic disorder, which usually manifests in infancy when fruit sugar is added to the diet. There is a diagnostic difference between HFI and fructose malabsorption, which is mainly associated with gastrointestinal symptoms.

 

Hereditary fructose intolerance leads to severe clinical symptoms when fruit sugar is ingested. Chronic exposure leads to failure to thrive and cirrhosis of the liver. Those affected often develop an aversion to sweet food, which can result in the disease remaining undiagnosed. Pathogenic variants in the fructose-bisphosphate aldolaseB (ALDOB) gene lead to an enzyme deficiency, which in turn leads to an accumulation of the toxic metabolite fructose-1-phosphate when fructose is consumed. The resulting inhibition of gluconeogenesis and glycogenolysis leads to hypoglycaemia with tremors, sweating and coma; there are also gastrointestinal complaints. Four common variants in the ALDOB gene, (p.(Ala150Pro), p.(Ala175Asp), p.(Asn335Lys) and the stop mutation p.(Tyr204*)), are responsible for approximately 85% of HFI cases in the European population; the variants p.(Ala150Pro) and p.(Ala175Asp) are pathogenic in over 50% of the cases. The disease has autosomal recessive inheritance, meaning both alleles must be affected for the enzyme deficiency to manifest clinically. The disease is rare, with an incidence of about 1:20,000 in the western population.

 

Another form of fructose intolerance with HFI-like symptoms is hereditary fructose-1,6-bis-phosphatase (FBP1) deficiency.

 

If HFI or FBP1 deficiency remains undetected and untreated, potentially life-threatening complications can occur, especially in infancy, and progressive organ damage can occur with time as the disease course progresses. In addition, treatment with drugs containing fructose, sucrose or sorbitol can lead to severe side effects.

 

Fructose intolerance can also be the result of disturbances in fructose transport in the intestine (fructose malabsorption) and chronic inflammatory intestinal diseases (e.g., Crohn's disease) (secondary form). These more frequent forms can occur at any age and are not based on a genetic disorder of fructose metabolism. Here, the gastrointestinal symptoms are predominant. In order to ensure targeted diagnostics, it is important to distinguish between the two forms in advance of a genetic examination.

 

References

Tran 2017, Nutrients 9:pii:E356 / Bijarnia-Mahay et al. 2015, JIMD Rep 19:85 / Ferri et al. 2012, JIMD Rep 6:31 / Grochota et al. 2006, Mol Gen Metab 87:376 / Santer et al. 2005, Hum Mut 6:594 / Sanchez-Gutierrez et al. 2002, J Med Gen 39:5

GENES

ALDOBFBP1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more